Established leader in large, growing and resilient addressable market

  • The largest private healthcare network in the UAE by bed count (1,660 beds) and private inpatient market share (19% in 2022)
  • The UAE, Oman & Saudi Arabia healthcare market represents a USD 69bn opportunity as of 2021, which is set to increase by a further 1.9x by 2031

Well-invested multi-brand network covering the full socio-economic spectrum

  • A portfolio of four well-known brands targeting the entire socio-economic spectrum, and creating a favourable negotiating position with insurance payers
  • Well invested network (AED 4.3bn total capex from inception) spanning 67 medical assets, including hospitals, medical centers and pharmacies
  • Strong investment in manpower has seen our team of clinically skilled and board-certified doctors grow by 53% since 2019 to 1,444 doctors

World-class super-specialty care offering driving patient yields

  • First mover and leading center in UAE for complex care, with transplant medicine, complex surgery, advanced oncology and other complex segments driving its patient yields growth (+9% ARR CAGR 2019-22)
  • Investing in healthcare partnerships to expand our complex service offering in the UAE in conjunction with internationally renowned providers

Accelerating digitization to drive operational and medical excellence

  • Digital health and digital transformation are key areas of investment across our network to optimize patient experience and maximize operational efficiencies
  • Our recently launched Patient Digital Channel continues to gain traction and now has  13% of total appointments

Expanding geographically through high-return and low-capex opportunities

  • Entry to high potential KSA market by introducing several low-capex, high-demand and locally-tailored healthcare products
  • Solid mid-term pipeline of completely de-risked and zero-capex public partnerships across MENA provides a huge bottom-line upside
  • Continued expanding our UAE healthcare infrastructure through adding 80 new in-demand specialized inpatient beds and five new medical centers in 2023

Cash-generative business model committed to delivering consistent shareholder return

  • Track record of strong financial performance and consistent growth, driven by the ramp-up of newly launched assets and supported by a focus on treating a higher-yielding patient mix in addition to cost optimization
  • Revenue CAGR of 17% over the past four years (FY 19-22), with impressive EBITDA CAGR (FY 19-22) of 28% and EBITDA margin expansion to 22% in FY 22
  • Robust margin expansion drivers coupled with compelling asset economics and strict capital discipline resulted in strong free cash flow generation capabilities (50% for H1 23)

Seasoned leadership team enabling aspirational ESG improvements

  • High quality management team with a wealth of industry experience (190+ total years’ experience) and a board that is 70% composed of independent non-executive directors
  • ESG principles serve as a fundamental foundation for sustainable growth and a crucial enabler of excellent patient outcomes, shareholder value and partnerships, opening potential commercial opportunities
  • Strong commitment to developing and implementing our long-term ESG strategy along with onboarding ESG ratings